Chemotherapy Available at Home with Launch of CTCA Program
“When the pandemic hit, telehealth was well positioned to be a powerful tool. It really was the silver lining in the entire shift in care.”
Cancer Treatment Centers of America’s pilot program, Oncology Clinic at Home, allows qualifying patients to receive their chemotherapy treatments in their own home.
Chevon Rariy, MD, medical director of Endocrinology at Cancer Treatment Centers of America (CTCA) Chicago, and the Telehealth Program director for the CTCA, recently spoke to Targeted Oncology®, sister publication of Oncology Nursing News®, about the effect of the pandemic on telehealth programs and the benefits that telehealth provides for patients with cancer.
The Oncology Clinic at Home program, which is currently based in Atlanta, Georgia, delivers oncology care to patients so long as they are in good enough health to not require a hospital visit, can tolerate their medication in an in-patient setting, have reliable internet service, own a mobile device such as a laptop or mobile, and have insurance policies which cover the treatments. The program currently treats breast, lung, prostate, head and neck, colorectal and some genitourinary cancers.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
